BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 29051052)

  • 81. Conditional Control of CRISPR/Cas9 Function.
    Zhou W; Deiters A
    Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Applications of CRISPR/Cas9 in Reproductive Biology.
    Khan FA; Pandupuspitasari NS; ChunJie H; Ahmad HI; Wang K; Ahmad MJ; Zhang S
    Curr Issues Mol Biol; 2018; 26():93-102. PubMed ID: 28879859
    [TBL] [Abstract][Full Text] [Related]  

  • 83. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Germline Cas9 expression yields highly efficient genome engineering in a major worldwide disease vector,
    Li M; Bui M; Yang T; Bowman CS; White BJ; Akbari OS
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10540-E10549. PubMed ID: 29138316
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Optimization of T-DNA configuration with UBIQUITIN10 promoters and tRNA-sgRNA complexes promotes highly efficient genome editing in allotetraploid tobacco.
    Kumar M; Ayzenshtat D; Marko A; Bocobza S
    Plant Cell Rep; 2022 Jan; 41(1):175-194. PubMed ID: 34623476
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Efficient and Heritable Targeted Mutagenesis in Mosses Using the CRISPR/Cas9 System.
    Nomura T; Sakurai T; Osakabe Y; Osakabe K; Sakakibara H
    Plant Cell Physiol; 2016 Dec; 57(12):2600-2610. PubMed ID: 27986915
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treating Genetic Disorders Using State-Of-The-Art Technology.
    Jamal M; Ullah A; Ahsan M; Tyagi R; Habib Z; Khan FA; Rehman K
    Curr Issues Mol Biol; 2018; 26():33-46. PubMed ID: 28879854
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
    Karvelis T; Gasiunas G; Siksnys V
    Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cas9/sgRNA-based genome editing and other reverse genetic approaches for functional genomic studies in rice.
    Moin M; Bakshi A; Madhav MS; Kirti PB
    Brief Funct Genomics; 2018 Sep; 17(5):339-351. PubMed ID: 29579147
    [TBL] [Abstract][Full Text] [Related]  

  • 91. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Creating Heritable Mutations in Drosophila with CRISPR-Cas9.
    Port F; Bullock SL
    Methods Mol Biol; 2016; 1478():145-160. PubMed ID: 27730579
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Multiplexed conditional genome editing with Cas12a in
    Port F; Starostecka M; Boutros M
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Fluorescence Marker-Assisted Isolation of Cas9-Free and CRISPR-Edited Arabidopsis Plants.
    Yu H; Zhao Y
    Methods Mol Biol; 2019; 1917():147-154. PubMed ID: 30610634
    [TBL] [Abstract][Full Text] [Related]  

  • 96. CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering.
    Labun K; Montague TG; Gagnon JA; Thyme SB; Valen E
    Nucleic Acids Res; 2016 Jul; 44(W1):W272-6. PubMed ID: 27185894
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus.
    Moyo B; Bloom K; Scott T; Ely A; Arbuthnot P
    Virus Res; 2018 Jan; 244():311-320. PubMed ID: 28087399
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Single transcript unit CRISPR 2.0 systems for robust Cas9 and Cas12a mediated plant genome editing.
    Tang X; Ren Q; Yang L; Bao Y; Zhong Z; He Y; Liu S; Qi C; Liu B; Wang Y; Sretenovic S; Zhang Y; Zheng X; Zhang T; Qi Y; Zhang Y
    Plant Biotechnol J; 2019 Jul; 17(7):1431-1445. PubMed ID: 30582653
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Application of CRISPR/Cas9 Nuclease in Amphioxus Genome Editing.
    Su L; Shi C; Huang X; Wang Y; Li G
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33167309
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Efficient genome editing in wheat using Cas9 and Cpf1 (AsCpf1 and LbCpf1) nucleases.
    Kim D; Hager M; Brant E; Budak H
    Funct Integr Genomics; 2021 Jul; 21(3-4):355-366. PubMed ID: 33710467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.